Detailled Information

Name of the Instrument/Tool ACR Neuropsychological Battery (ACR-NB)
First Description

Ad Hoc Committee on Lupus Response Criteria: Cognition Sub-committee, Mikdashi JA, Esdaile JM, Alarcón GS, Crofford L, Fessler BJ, Shanberg L, Brunner H, Gall V, Kalden JR, Lockshin MD, Liang MH, Roberts N Jr, Schneider M. Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus. 2007;16(6):418-25.

Year 2007
Domains
Concept of constructs Self-management, Impact of disease
Population/Disease Disease specific
Originally developed for Systemic Lupus Erythematosus (SLE)
Other rheumatic diseases
where can be applied (only if validated)
Rheumatoid Arthritis (RA)
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language Spanish, French, Mandarin, Japanese, Korean
REFERENCE IDENTIFICATION
Author/s Ad Hoc Committee on Lupus Response Criteria: Cognition Sub-committee, Mikdashi JA, Esdaile JM, Alarcón GS, Crofford L, Fessler BJ, Shanberg L, Brunner H, Gall V, Kalden JR, Lockshin MD, Liang MH, Roberts N Jr, Schneider M.
Title Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials
Journal Lupus
Year 2007
Vol 16
Num 6
Pages 418-25
Country USA
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/15478145/
Brief Description

Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus

Link https://pubmed.ncbi.nlm.nih.gov/31628718/
Brief Description

Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus

Link https://pubmed.ncbi.nlm.nih.gov/33091255/
Brief Description

Measures of Cognition in Rheumatic Diseases

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to Jamal A Mikdashi
E-Mail jmikdash@umaryland.edu
Address Division of Rheumatology and Clinical Immunology, 10 South Pine Street, Suite 834, Baltimore, MD 21201, USA
Website ---
Available See other comments
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Item Bank
Brief Description

The ACR-NB measures cognitive deficits in adult patients with SLE and assesses changes over time.

The ACR-NB consists of 10 neuropsychological tests, as reported by the Ad Hoc Committee on Lupus Response Criteria: Cognition Sub-committee in 2007. The National Adult Reading Test (NART) is used to estimate the intelligence quotient. The Revised Wechsler Adult Intelligence Scale (WAIS-R) Digit Symbol Substitution Test measures associative learning, motor speed, attention, and visuoperceptual functions. The Trail Making Test Part B measures executive function, flexibility, and visuomotor skills. The Stroop Color and Word Test measures cognitive flexibility and interference. The California Verbal Learning Test (CVLT) measures verbal learning and memory. The Rey-Osterrieth Complex Figure Test (RCFT) measures visuospatial ability and visuospatial memory. The WAIS, third edition, (WAIS-III) letter number sequencing measures verbal working memory. The COWAT measures letter fluency, and the Animal Naming Test measures category fluency. The Finger Tapping Test measures simple fine motor speed. Overall, the cognitive domains covered in the battery include manual motor speed, attention, processing speed, language processing, learning and memory (visuospatial and verbal), and executive functioning, which have been shown to be affected in SLE. Some domains include multiple neuropsychological tests that measure the particular cognitive function.

Number of Items 10 test
Range ---
Responses options/scale Yes
Unique to each test in the battery
Developed for ---
PRACTICAL APPLICATION
Method of administration Physician
Recommendations to score

Raw scores are recorded for all tests. Depending on the test manual, they may be converted to Z or T scores for comparison with normative data stratified by age and sex.

Once scores have been recorded and converted to either Z or T scores, they are compared with published normative data appropriate for age, education, sex, and ethnic group or with control subjects. The ACR committee reported the following scoring system to correspond with the ACR-NB: Scores of 2 or more SDs below the estimated population mean in domains of attention, memory, and psychomotor speed are interpreted as CI. Scores of 1.5 to 1.9 SDs below the mean are deemed cognitive decline. Focal impairment was defined as one or more tests within one domain affected, and multifocal impairment was defined as two or more domains affected. However, the definition of CI varies and is not standardized in all studies. In RA, impairment was defined as a score of 1 SD below age-stratified population norms for each cognitive test. A total cognitive function score (a summation of all test scores indicating impairment) of 4 or more indicated CI. Another study in SLE defined CI as a Z score of −1.5 or less in two or more domains, defined cognitively normal as Z scores in all domains greater than −1.5, and defined indeterminate as a Z score of −1.5 or less in only one domain

Score Interpretation ---
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient 60 minutes
Scoring time by the assessor 60 minutes
Training to score Not necessary
Strengths Useful in clinical practice & research
Limitations Ceiling effect
OTHER COMMENTS
Other Comments

For further information, please contact the developers